MENU
URGN
AS OF
Nov 13, 04:59 PM (EDT)
Price
$23.94
Change
-$1.20 (-4.77%)
Capitalization
1.18B
119 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

UroGen Pharma (URGN) Earnings Date & Reports

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

URGN is expected to report earnings to fall 28.52% to -49 cents per share on March 12

UroGen Pharma URGN Stock Earnings Reports
Q4'25
Est.
$-0.49
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.22
Q1'25
Missed
by $0.13
Q4'24
Missed
by $0.03
The last earnings report on November 06 showed earnings per share of -68 cents, missing the estimate of -68 cents. With 447.80K shares outstanding, the current market capitalization sits at 1.18B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
URGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. URGN showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for URGN
A.I. Advisor
published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com